Related Experiment Video
Updated: Jan 19, 2026

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
Published on: August 23, 2024
[Two Cases of Endobronchial Metastases from Breast Cancer]
Kazuya Miyoshi1, Hirotoshi Takahashi, Kenji Takahashi
1Dept. of Breast &s Endocrine Surgery, NHO Fukuyama Medical Center.
Abstract:
Endobronchialmetastasis(EBM)is a rare complication in breast cancer patients. Herein, we report 2 cases of EBM in breast cancer patients. Patient 1 had pulmonary metastases that were treated with hormone therapy and showed long survival after achieving a CR, while patient 2 had multi-organ metastases and died 42 months after the diagnosis of EBM. If bronchial obstruction is observed in a breast cancer patient, early diagnosis of EBM via a bronchoscopic examination is recommended. EBM may not indicate a poor prognosis, and appropriate anti-cancer therapy with palliative intrabronchial therapies can prolong the survival in selected EBM patients.
More Related Videos
Related Concept Videos
09:48Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
08:36Ultrasound Imaging-guided Intracardiac Injection to Develop a Mouse Model of Breast Cancer Brain Metastases Followed by Longitudinal MRI
05:02Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells
07:47Studying the Role of Alveolar Macrophages in Breast Cancer Metastasis
09:29Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
07:45Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer

